Skip to main content

Iradimed Corp

IRMD
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001325618

In the last 90 days, Iradimed Corp insiders filed 0 open-market purchases and 1 sale; 213 institutions reported holding it in 13F filings for Q2 2026, worth $750.2M in total; no superinvestor holds it.

Holders of 5% or more of IRMD

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Iradimed Corp, largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of IRMD
HolderLatest formStakeChangeFirst filedLatest filingFiling
Susi Roger E.13G/A34.80%4.45M shares–May 14, 20261 filingMay 14, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

4 Schedule 13D and 13G filings on Iradimed Corp, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on IRMD
Filed (ET)FilerFormStakeChangeEvent dateFiling
May 14, 20265:16 PM ETSusi Roger E.and 4 others13G/A34.80%4.45M shares–Mar 31, 2026SEC
Feb 10, 20261:20 PM ETNine Ten Capital Management LLCand 2 others13G/A3.40%428.5K shares−3.70 ppfrom 7.10%Below 5%Dec 31, 2025SEC
Apr 29, 202511:59 AM ETBlackRock, Inc.13G/A3.90%496.6K shares–Below 5%Mar 31, 2025SEC
Feb 13, 20251:28 PM ETNine Ten Capital Management LLCand 2 others13G7.10%905.9K sharesNewDec 31, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Iradimed Corp shares.

No Form 144 notices for Iradimed Corp are on file.